A 20-year trend of prevalence and susceptibility to trimethoprim/sulfamethoxazole of Stenotrophomonas maltophilia in a single secondary care hospital in Korea
被引:6
作者:
论文数: 引用数:
h-index:
机构:
Song, Je Eun
[1
]
Kim, Sollip
论文数: 0引用数: 0
h-index: 0
机构:
Univ Ulsan, Asan Med Ctr, Dept Lab Med, Coll Med, Seoul, South KoreaInje Univ, Infect Dis Internal Med, Ilsan Paik Hosp, Goyang, South Korea
Kim, Sollip
[2
]
论文数: 引用数:
h-index:
机构:
Kwak, Yee Gyung
[1
]
论文数: 引用数:
h-index:
机构:
Shin, Sunghwan
[3
]
Um, Tae-Hyun
论文数: 0引用数: 0
h-index: 0
机构:
Inje Univ, Dept Lab Med, Ilsan Paik Hosp, 170 Juhwa Ro, Goyang 10380, Gyeonggi Do, South KoreaInje Univ, Infect Dis Internal Med, Ilsan Paik Hosp, Goyang, South Korea
Um, Tae-Hyun
[3
]
Cho, Chong Rae
论文数: 0引用数: 0
h-index: 0
机构:
Inje Univ, Dept Lab Med, Ilsan Paik Hosp, 170 Juhwa Ro, Goyang 10380, Gyeonggi Do, South KoreaInje Univ, Infect Dis Internal Med, Ilsan Paik Hosp, Goyang, South Korea
Cho, Chong Rae
[3
]
论文数: 引用数:
h-index:
机构:
Chang, Jeonghyun
[3
]
机构:
[1] Inje Univ, Infect Dis Internal Med, Ilsan Paik Hosp, Goyang, South Korea
[2] Univ Ulsan, Asan Med Ctr, Dept Lab Med, Coll Med, Seoul, South Korea
[3] Inje Univ, Dept Lab Med, Ilsan Paik Hosp, 170 Juhwa Ro, Goyang 10380, Gyeonggi Do, South Korea
Stenotrophomonas maltophilia is a Gram-negative opportunistic pathogen that can cause serious infection. We aimed to analyze the prevalence and susceptibility rates to trimethoprim/sulfamethoxazole of S. maltophilia. We conducted a retrospective study of S. maltophilia isolates from a university hospital from 2001 to 2020. Clinical information, the numbers of isolates and susceptibility rates were analyzed by year. Susceptibility rates and changes in respiratory and non-respiratory samples were compared. 1805 S. maltophilia isolates were identified, of which 81.4% (1469/1805) were from respiratory samples. There was a male predominance and 52% of the isolates were from general wards. The average susceptibility rate was 87.7% and there was no significant annual trend (P = .519). The susceptibility rate was 88.7% in respiratory samples and 84.1% in non-respiratory samples (P = .018). Susceptibility analyses using clinical data over long periods can guide the choice of antimicrobials especially for pathogen whose treatment options are limited.